Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks Consensus Estimate of $5.03 per share. Earnings rose 114% year over year.

Semaglutide is approved as Ozempic pre-filled pen and Rybelsus oral tablet for ... to increase 19-27% at CER Among the growth products, Trulicity generated revenues worth $1.25 billion, down ...

Higher volumes of drugs like Mounjaro, Zepbound, Verzenio, Jardiance and Taltz were partially offset by lower sales of Trulicity. Lilly’s new products also contributed to sales growth.

One of the best things about compounded semaglutide (besides the accessible price) is that it typically comes in vials rather than prefilled injection pens. This gives healthcare providers a lot ...

A pre-filled pen containing four weekly doses of 1mg Ozempic is priced ... Dulaglutide is marketed by Eli Lilly under the brand name Trulicity for the treatment of type 2 diabetes and is registered ...

The Nintendo Switch 2 is real. Finally, after months of rumors and speculation (and a recent flurry of leaks), Nintendo has confirmed one of the worst-kept secrets in gaming, its next console is a ...